DELFI Diagnostics

Palo Alto, United States

DELFI's AI platform uses whole-genome sequencing to detect cancer-associated cfDNA fragmentation patterns in the blood.

$225.0M raised

Jul 2022

Series B

Artificial Intelligence (AI)Biotechnology Health Care Health Diagnostics Medical

Top Investors

Menlo Ventures Eli Lilly Samsara BioCapital Point72 OrbiMed

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about DELFI Diagnostics

How much funding has DELFI Diagnostics raised?

DELFI Diagnostics has raised $225.0M in total funding. The most recent round was Series B. The last funding was announced in July 2022.

Who are DELFI Diagnostics's investors?

DELFI Diagnostics's investors include Menlo Ventures, Eli Lilly, Samsara BioCapital, Point72, OrbiMed.

Where is DELFI Diagnostics headquartered?

DELFI Diagnostics is headquartered in Palo Alto, United States.

What does DELFI Diagnostics do?

DELFI's AI platform uses whole-genome sequencing to detect cancer-associated cfDNA fragmentation patterns in the blood.

What stage is DELFI Diagnostics at?

DELFI Diagnostics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 18, 2022.

MLA

"DELFI Diagnostics — Funding & Investors." VCBacked, July 18, 2022, https://www.vcbacked.co/company/delfi-diagnostics. Accessed July 1, 2026.

APA

VCBacked. (2022). DELFI Diagnostics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/delfi-diagnostics

Wikipedia (cite web)

{{cite web |title=DELFI Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/delfi-diagnostics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 18, 2022.

Similar Companies in Artificial Intelligence (AI)

Fort Lauderdale$50.0M